Cronos Group earnings were $57.8M for the trailing 12 months ending Sep 30, 2026, with 54.5% growth year over year. The latest CRON earnings report on Sep 30, 2026 announced Q3 2026 earnings of $13.8M, down 57% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CRON reported annual earnings of -$9.4M, with -123% growth.
CRON past earnings growth
How has CRON's earnings growth performed historically?
On CRON's earnings call on Nov 5, 2026, Cronos Group (NASDAQ: CRON) reported Q3 2026 earnings per share (EPS) of $0.04, up 42.86% year over year. Total CRON earnings for the quarter were $13.80 million. In the same quarter last year, Cronos Group's earnings per share (EPS) was $0.07.
As of the last Cronos Group earnings report, Cronos Group is currently profitable. Cronos Group's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $57.83 million, a 60.19% increase year over year.
What was CRON's earnings growth in the past year?
As of Cronos Group's earnings date in Nov 5, 2026, Cronos Group's earnings has grown 54.55% year over year. This is 3.53 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 51.02%. CRON earnings in the past year totalled $57.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.